Typography

Tahoma Engineered Solutions Promotes Michele Gesing to Production Scheduler

Retrieved on: 
Thursday, July 22, 2021

ASHLAND, Ohio, July 22, 2021 /PRNewswire/ -- Tahoma Engineered Services, a leading manufacturer of precision machined parts and wire formed products, recently promoted Michele Gesing into the position of Production Scheduler.

Key Points: 
  • ASHLAND, Ohio, July 22, 2021 /PRNewswire/ -- Tahoma Engineered Services, a leading manufacturer of precision machined parts and wire formed products, recently promoted Michele Gesing into the position of Production Scheduler.
  • "One of her first projects in this role will be implementing the advanced scheduler portion of our management software system."
  • Before joining Tahoma Engineered Services, Gesing gained more than 10 years of professional experience in working in a manufacturing environment.
  • Tahoma Engineered Solutions, a business unit of Tahoma Enterprises, is ISO 9001-2015 certified.

Immuneering Appoints Michael Bookman as General Counsel and Secretary

Retrieved on: 
Tuesday, July 20, 2021

CAMBRIDGE, Mass., July 20, 2021 (GLOBE NEWSWIRE) -- Immuneering Corporation (Immuneering), a private biopharmaceutical company advancing a robust pipeline of oncology and neuroscience drug candidates that are designed to uniquely disrupt cellular signaling dynamics, today announced the appointment of Michael Bookman to the newly created position of General Counsel and Secretary, effective immediately.

Key Points: 
  • CAMBRIDGE, Mass., July 20, 2021 (GLOBE NEWSWIRE) -- Immuneering Corporation (Immuneering), a private biopharmaceutical company advancing a robust pipeline of oncology and neuroscience drug candidates that are designed to uniquely disrupt cellular signaling dynamics, today announced the appointment of Michael Bookman to the newly created position of General Counsel and Secretary, effective immediately.
  • We are delighted to welcome him to the Immuneering team, stated Ben Zeskind, Ph.D., Co-Founder and Chief Executive Officer of Immuneering.
  • I look forward to working with this dynamic management team to build Immuneering into a leading biopharmaceutical company, said Mr. Bookman.
  • Mr. Bookman joins Immuneering from Frequency Therapeutics (Frequency), where he served as General Counsel and Secretary since 2019.

Monotype Introduces Helvetica Now Variable Font, Including Over 1 Million New Styles

Retrieved on: 
Tuesday, July 13, 2021

Monotype today introduced Helvetica Now Variable, offering over a million new Helvetica Now styles in one state-of-the-art font file.

Key Points: 
  • Monotype today introduced Helvetica Now Variable, offering over a million new Helvetica Now styles in one state-of-the-art font file.
  • Helvetica Now Variable builds on the 2019 release of Helvetica Now , which reimagined the clarity, simplicity and neutrality of classic Helvetica with 21st-century design needs including optical sizing, stylistic alternates and an extended character set.
  • The incredibly positive reception to Helvetica Now makes us proud to build upon this time-tested design even further, said Charles Nix, Creative Type Director at Monotype.
  • Moreover, its just plain fun, with the potential to bring the good news of variable fonts to the masses.

Glowforge Hires Megan Lutes as General Counsel

Retrieved on: 
Monday, July 12, 2021

Glowforge , the Seattle-based company that designs and produces iconic 3D laser printers for home and small business use, today announced that it has hired Megan Lutes as general counsel.

Key Points: 
  • Glowforge , the Seattle-based company that designs and produces iconic 3D laser printers for home and small business use, today announced that it has hired Megan Lutes as general counsel.
  • Lutes joins the leadership team at Glowforge at a period of rapid growth and will lead the companys legal function.
  • Glowforge has a vision to create a world where anyone can print anything, said Glowforge founder and CEO, Dan Shapiro.
  • Im excited to be joining such an innovative and transformative company as Glowforge, said Lutes.

Monotype Announces iType 6.0, Further Enabling Variable Fonts in Embedded Environments.

Retrieved on: 
Thursday, July 8, 2021

Monotype today announced the launch of iType 6.0, a new version of its hugely popular product for embedded solutions.

Key Points: 
  • Monotype today announced the launch of iType 6.0, a new version of its hugely popular product for embedded solutions.
  • Monotypes iType font engine is a scalable font rendering subsystem based on industry standard TrueType and OpenType font standards.
  • Version 6.0 of the iType font engine is designed to add support for OpenType Font Variations, commonly known as variable fonts.
  • Other key features being introduced in this version include:
    For more details about variable fonts, visit the Monotype resource page .

Global Industrial Inkjet Printers Market (2021 to 2028) - COVID-19 Impact and Analysis

Retrieved on: 
Thursday, July 8, 2021

DUBLIN, July 8, 2021 /PRNewswire/ -- The "Industrial Inkjet Printers Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Technology; End User and Geography" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, July 8, 2021 /PRNewswire/ -- The "Industrial Inkjet Printers Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Technology; End User and Geography" report has been added to ResearchAndMarkets.com's offering.
  • The rising global packaging industry, combined with the faster operating speeds provided by industrial inkjet printers, is anticipated to increase the use of industrial inkjet printers in packaging.
  • Based on end user, the industrial inkjet printers market is segmented into food and beverages, automobile, packaging, cosmetic, medical, and others.
  • Features key findings and crucial progressive industry trends in the global industrial inkjet printers market, thereby allowing players to develop effective long-term strategies.

$9+ Billion Industrial Inkjet Printers Global Market to 2028 - by Technology, End-user and Geography - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 8, 2021

The "Industrial Inkjet Printers Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Technology; End User and Geography" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Industrial Inkjet Printers Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Technology; End User and Geography" report has been added to ResearchAndMarkets.com's offering.
  • The rising global packaging industry, combined with the faster operating speeds provided by industrial inkjet printers, is anticipated to increase the use of industrial inkjet printers in packaging.
  • Based on end user, the industrial inkjet printers market is segmented into food and beverages, automobile, packaging, cosmetic, medical, and others.
  • Features key findings and crucial progressive industry trends in the global industrial inkjet printers market, thereby allowing players to develop effective long-term strategies.

Myriad Genetics Completes Sale of Myriad RBM to IQVIA’s Q2 Solutions

Retrieved on: 
Thursday, July 1, 2021

SALT LAKE CITY, July 01, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that it has completed the sale of its wholly-owned subsidiary, Myriad RBM, Inc. to Q2 Solutions, a leading global clinical trial laboratory services organization, and a wholly owned subsidiary of IQVIA.

Key Points: 
  • SALT LAKE CITY, July 01, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that it has completed the sale of its wholly-owned subsidiary, Myriad RBM, Inc. to Q2 Solutions, a leading global clinical trial laboratory services organization, and a wholly owned subsidiary of IQVIA.
  • Q2 Solutions provides comprehensive testing, project management, supply chain, biorepository, biospecimen and consent tracking solutions.
  • Myriad RBM, which specializes in laboratory services for clinical research for the pharmaceutical industry, will be added to the overall Q2 Solutions menu and offerings.
  • Myriad, the Myriad logo, BART, BRACAnalysis, Colaris, Colaris AP, myRisk, Myriad myRisk, myRisk Hereditary Cancer, myChoice, myPlan, BRACAnalysis CDx, Tumor BRACAnalysis CDx, myChoice CDx, Vectra, EndoPredict, Prequel, Foresight, GeneSight, riskScore and Prolaris are trademarks or registered trademarks of Myriad Genetics, Inc. or its wholly owned subsidiaries in the United States and foreign countries.

Christopher Slye joins Type Network

Retrieved on: 
Wednesday, June 30, 2021

BOSTON, June 30, 2021 /PRNewswire/ -- Type Network, which represents 32 of the best type foundries in the world, has a new president: Christopher Slye.

Key Points: 
  • BOSTON, June 30, 2021 /PRNewswire/ -- Type Network, which represents 32 of the best type foundries in the world, has a new president: Christopher Slye.
  • "This is a great opportunityto work with so many people who design and use type, and to build new relationships as the network grows," Christopher said.
  • Christopher notes that, among the thousands of type styles in its library, Type Network also offers fonts for all Latin languages, as well as Cyrillic Greek, Arabic, and Hebrew scripts.
  • "We've built a successful service for foundries and users of type over the past five years and I'm looking forward to watching Type Network grow and evolve under Christopher's leadership,"he said.

ArcelorMittal Announces the Results of its Offer to Purchase for Cash Any and All of its 3.600% Notes due 2024, 6.125% Notes due 2025 and 4.550% Notes due 2026

Retrieved on: 
Friday, June 25, 2021

King has been retained to serve as the information agent and tender agent in connection with the Offers.

Key Points: 
  • King has been retained to serve as the information agent and tender agent in connection with the Offers.
  • Capitalized terms used and not defined herein have the meanings ascribed to them in the Offer to Purchase.
  • This announcement must be read in conjunction with the Offer to Purchase and the announcement dated June 17, 2021.
  • The distribution of this announcement and the Offer to Purchase in certain jurisdictions may be restricted by law.